EIF4E and non-small cell lung carcinoma: RNA level of exo-eIF4E was associated with some clinicopathological features, including TNM stage, distant metastasis, and the level of CYFRA21-1, thus implying that exo-eIF4E could be a prognostic biomarker for NSCLC patients.